rosiglitazone has been researched along with Renal Insufficiency in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andresen, BT; Lu, N; Trivedi, H; Whaley-Connell, A | 1 |
| Brookes, ZL; Huang, L; Nauli, SM; Ong, AC; Prasad, S; Ruff, L; Solanky, T; Upadhyay, VS | 1 |
| Braddon, J; Phillips, P | 1 |
| Blum, R; Chapelsky, MC; Freed, MI; Miller, AK; Sack, M; Thompson-Culkin, K | 1 |
| Agrawal, A; Jones, NP; Sautter, MC | 1 |
| Alemao, E; Chen, J; Cook, J; Yin, D | 1 |
1 review(s) available for rosiglitazone and Renal Insufficiency
| Article | Year |
|---|---|
Oral hypoglycaemics. When not to use what.
Topics: Acarbose; Acidosis, Lactic; Aged; Contraindications; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Pioglitazone; Renal Insufficiency; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
2 trial(s) available for rosiglitazone and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency.
Topics: Administration, Oral; Adolescent; Adult; Aged; Area Under Curve; Creatinine; Female; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Renal Insufficiency; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2003 |
3 other study(ies) available for rosiglitazone and Renal Insufficiency
| Article | Year |
|---|---|
Slower decline of renal function after initiation of rosiglitazone in diabetics -- a pilot study.
Topics: Aged; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypoglycemic Agents; Male; Pilot Projects; Renal Insufficiency; Rosiglitazone; Thiazolidinediones; Time Factors | 2009 |
Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.
Topics: Animals; Antioxidants; Arterioles; Calcium; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Genotype; Heterozygote; Hypertension; Male; Mesentery; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Phenotype; Polycystic Kidney, Autosomal Dominant; PPAR gamma; Renal Insufficiency; Reperfusion Injury; Rosiglitazone; Superoxides; Thiazolidinediones; Time Factors; TRPP Cation Channels; Vasodilation; Vasodilator Agents; Venules | 2013 |
Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications.
Topics: Amputation, Surgical; Blindness; Cardiovascular Diseases; Computer Simulation; Diabetes Complications; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Models, Biological; Prognosis; Renal Insufficiency; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; United Kingdom | 2008 |